Drug Database
Back to search

France· FR:68131878

CORVASAL 2 mg, comprimé sécable

A molsidomine product containing molsidomine, registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC C01DX12

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCORVASAL 2 mg, comprimé sécableATCC01DX12REGISTER NO.FR:68131878PACKS LISTED3CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about molsidomineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Molsidomine is registered in 8 of 19 countries.

Countries holding a registration under ATC C01DX12 (molsidomine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose
Search molsidomine products by name

Molsidomine · ATC C01DX12

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of molsidomine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.33 in France to $0.63 in Switzerland — a ×1.9 gap.

  • France: $0.33 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Molsidomine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.63
  • FR France$0.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MOLSIDOMINE
Manufacturer
CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
Country
France (FR)
ATC code
C01DX12
ATC class
Molsidomine
Defined daily dose
8 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 3

2 priced
  • cip13
    3400932410811
    plaquette(s) PVC-Aluminium de 30 comprimé(s)
    EUR 3.72
  • cip13
    3400932411061
    plaquette(s) PVC-Aluminium de 90 comprimé(s)
    EUR 9.95
  • cip13
    3400955665168
    plaquette(s) PVC-Aluminium de 100 comprimé(s) ( abrogée le 07/09/2023)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for molsidomine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check molsidomine against other medicinesHow interaction checks work

Molsidomine · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Molsidomine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All molsidomine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Molsidolat
  • Belgium · Coruno, Corvaton
  • Bulgaria · Молсидомин Wzf, Сиднофарм
  • Czechia · Corvaton Forte
  • Germany · Corvaton, Corvaton Forte
  • Spain · Molsidain
  • Hungary · Corvaton, Corvaton Forte
  • Lithuania · Molsidominum Pph
  • Luxembourg · Coruno, Corvaton
  • Poland · Molsidomina Wzf
  • Slovakia · Corvaton, Corvaton Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/08d3979d-6726-4457-8b50-8ea6b9d9a985
GET /v1/drugs/08d3979d-6726-4457-8b50-8ea6b9d9a985?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68131878",
  "date_amm": "1980-12-12",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MOLSIDOMINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about molsidomine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console